Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South Korea Ascites Market

ID: MRFR/HC/54587-HCR
200 Pages
Satyendra Maurya
Last Updated: March 28, 2026

South Korea Ascites Market Research Report: By Type (Transudative Ascites, Exudate Ascites), By Diagnosis (Ultrasound, CT Scan, Laparoscopy, Angiography), By Treatment (Surgeries) andBy End User (Hospitals & Clinics, Ambulatory Surgical Center, Diagnostic Centers)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 South Korea Ascites Market, BY Application (USD Million)
      1. 4.1.1 Diagnostic
      2. 4.1.2 Therapeutic
      3. 4.1.3 Prognostic
      4. 4.1.4 Research
    2. 4.2 South Korea Ascites Market, BY Type of Ascites (USD Million)
      1. 4.2.1 Transudative
      2. 4.2.2 Exudative
      3. 4.2.3 Malignant
      4. 4.2.4 Cirrhotic
    3. 4.3 South Korea Ascites Market, BY Treatment Method (USD Million)
      1. 4.3.1 Paracentesis
      2. 4.3.2 Diuretics
      3. 4.3.3 Surgical Intervention
      4. 4.3.4 Transplantation
    4. 4.4 South Korea Ascites Market, BY Patient Demographics (USD Million)
      1. 4.4.1 Age Group
      2. 4.4.2 Gender
      3. 4.4.3 Underlying Conditions
      4. 4.4.4 Socioeconomic Status
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the South Korea Ascites Market
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the South Korea Ascites Market
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Samsung Biologics (KR)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Celltrion (KR)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Hanmi Pharmaceutical (KR)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 LG Chem (KR)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 SK Biopharmaceuticals (KR)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Daewoong Pharmaceutical (KR)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Korea United Pharm (KR)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Medytox (KR)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    3. 6.3 SOUTH KOREA MARKET ANALYSIS BY TYPE OF ASCITES
    4. 6.4 SOUTH KOREA MARKET ANALYSIS BY TREATMENT METHOD
    5. 6.5 SOUTH KOREA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    6. 6.6 KEY BUYING CRITERIA OF SOUTH KOREA ASCITES MARKET
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF SOUTH KOREA ASCITES MARKET
    9. 6.9 DRIVERS IMPACT ANALYSIS: SOUTH KOREA ASCITES MARKET
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: SOUTH KOREA ASCITES MARKET
    11. 6.11 SUPPLY / VALUE CHAIN: SOUTH KOREA ASCITES MARKET
    12. 6.12 SOUTH KOREA ASCITES MARKET, BY APPLICATION, 2024 (% SHARE)
    13. 6.13 SOUTH KOREA ASCITES MARKET, BY APPLICATION, 2024 TO 2035 (USD Million)
    14. 6.14 SOUTH KOREA ASCITES MARKET, BY TYPE OF ASCITES, 2024 (% SHARE)
    15. 6.15 SOUTH KOREA ASCITES MARKET, BY TYPE OF ASCITES, 2024 TO 2035 (USD Million)
    16. 6.16 SOUTH KOREA ASCITES MARKET, BY TREATMENT METHOD, 2024 (% SHARE)
    17. 6.17 SOUTH KOREA ASCITES MARKET, BY TREATMENT METHOD, 2024 TO 2035 (USD Million)
    18. 6.18 SOUTH KOREA ASCITES MARKET, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE)
    19. 6.19 SOUTH KOREA ASCITES MARKET, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million)
      2. 7.2.2 BY TYPE OF ASCITES, 2026-2035 (USD Million)
      3. 7.2.3 BY TREATMENT METHOD, 2026-2035 (USD Million)
      4. 7.2.4 BY PATIENT DEMOGRAPHICS, 2026-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

South Korea Ascites Market Segmentation

South Korea Ascites Market By Application (USD Million, 2022-2035)

  • Diagnostic
  • Therapeutic
  • Prognostic
  • Research

South Korea Ascites Market By Type of Ascites (USD Million, 2022-2035)

  • Transudative
  • Exudative
  • Malignant
  • Cirrhotic

South Korea Ascites Market By Treatment Method (USD Million, 2022-2035)

  • Paracentesis
  • Diuretics
  • Surgical Intervention
  • Transplantation

South Korea Ascites Market By Patient Demographics (USD Million, 2022-2035)

  • Age Group
  • Gender
  • Underlying Conditions
  • Socioeconomic Status

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions